© Reuters. FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo
(Reuters) – Abbott Laboratories (NYSE:) said on Monday it has entered into an agreement with the U.S. Food and Drug Administration on the steps necessary to resume production and maintain its baby formula facility at Sturgis, Michigan.
Be the first to comment